The financial generosity of the pharmaceutical industry to provide funding for medical education tempts a compromise of professional standards and ethics.
In April 2002, many pharmaceutical companies adopted PhRMA code, an attempt to self-regulate the pharmaceutical industry's marketing to physicians and other health care professionals.
An ethical case explores whether a medical student doing a radiology rotation has a duty to inform a patient whose chest x-ray shows bony metastases that was not caught by the original radiologist or mentioned in the ED chart.